OR WAIT null SECS
October 25, 2022
Under two new agreements, Societal CDMO will offer analytical, technical transfer, formulation, manufacturing, and packaging services for novel therapeutics.
Under the new collaboration with Tempus, GSK will have access to de-identified patient data to accelerate drug discovery, improve clinical trial design, and speed up enrollment.
October 21, 2022
Aenova Group and Microcaps are partnering to enable new customized formulations for product development and life cycle management solutions.
October 19, 2022
Gilead and MacroGenics will work together on bispecific antibodies for the treatment of blood cancers.
October 14, 2022
Merck has exercised a $250 million option with Moderna to jointly develop and commercialize cancer vaccine mRNA-4157/V940.
Alexion’s acquisition of LogicBio is designed to accelerate the company’s growth in genomic medicines.
October 12, 2022
Eli Lilly and Company will partner with Schrödinger to develop and optimize small molecule compounds.
Agilent Technologies opened a Dissolution Center of Excellence in Craven Arms, United Kingdom, on Oct. 12, 2022.
October 10, 2022
Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities.
Amphista Therapeutics and Domainex will work together to develop treatments focusing on targeted protein degradation.